Lipid-based nanoparticle formulation of diallyl trisulfide chemosensitizes the growth inhibitory activity of doxorubicin in colorectal cancer.
PMID: Molecules. 2022 Mar 28; 27 (7). Epub 2022 Mar 28. PMID: 35408590 Abstract Title: Lipid-Based Nanoparticle Formulation of Diallyl Trisulfide Chemosensitizes the Growth Inhibitory Activity of Doxorubicin in Colorectal Cancer Model: A Novel In Vitro, In Vivo and In Silico Analysis. Abstract: Garlic’s main bioactive organosulfur component, diallyl trisulfide (DATS), has been widely investigated … Read more